Allurion Technologies

Allurion Technologies is a commercial-stage medical device company pioneering a non-surgical, procedure-less weight loss intervention. Its core innovation is the Allurion Smart Capsule, an FDA-approved gastric balloon system that patients swallow, eliminating the need for endoscopic placement and removal, thereby reducing cost, complexity, and patient apprehension. The integrated Allurion Program combines the device with a digital platform for patient monitoring and behavioral coaching, targeting the global obesity epidemic. With over 200,000 patients treated internationally, the company is establishing a new standard in accessible, non-invasive metabolic care.

Integrated weight loss platform featuring a swallowable, procedure-less gastric balloon (Smart Capsule) that deploys and removes without endoscopy, combined with a digital ecosystem for remote patient monitoring, AI coaching (Coach Iris), and clinician dashboards.

Allurion competes in the medical weight loss space against endoscopic gastric balloons (e.g., Orbera, ReShape), prescription anti-obesity medications (particularly GLP-1 agonists like semaglutide and tirzepatide), and bariatric surgery. Its primary differentiation is the procedure-less placement and removal of its balloon, reducing cost, complexity, and patient apprehension compared to endoscopic alternatives.